%0 Journal Article
%T The Delivery of mRNA Vaccines for Therapeutics.
%A Nitika 
%A Wei J
%A Hui AM
%A Nitika 
%A Wei J
%A Hui AM
%A Nitika 
%A Wei J
%A Hui AM
%J Life (Basel)
%V 12
%N 8
%D Aug 2022 17
%M 36013433
%F 3.251
%R 10.3390/life12081254
%X mRNA vaccines have been revolutionary in combating the COVID-19 pandemic in the past two years. They have also become a versatile tool for the prevention of infectious diseases and treatment of cancers. For effective vaccination, mRNA formulation, delivery method and composition of the mRNA carrier play an important role. mRNA vaccines can be delivered using lipid nanoparticles, polymers, peptides or naked mRNA. The vaccine efficacy is influenced by the appropriate delivery materials, formulation methods and selection of a proper administration route. In addition, co-delivery of several mRNAs could also be beneficial and enhance immunity against various variants of an infectious pathogen or several pathogens altogether. Here, we review the recent progress in the delivery methods, modes of delivery and patentable mRNA vaccine technologies.